SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Conatus Pharmaceuticals Q3 EPS $(0.1) Up From $(0.15) YoY, Sales $3.376M Down From $7.666M YoY

Conatus Pharmaceuticals (NASDAQ:CNAT) reported quarterly losses of $(0.1) per share. This is a 33.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported $3.376 million

Benzinga · -

Conatus Pharmaceuticals (NASDAQ:CNAT) reported quarterly losses of $(0.1) per share. This is a 33.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported $3.376 million in sales this quarter. This is a 55.96 percent decrease over sales of $7.666 million the same period last year.